We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$61.9B
1-Year Est. Return
29.81%
This Fund
S&P 500
This Quarter
Est. Return
+4.72%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
–
AUM
$52.2B
AUM Growth
+$1.16B
(+2.3%)
Cap. Flow
-$268M
Cap. Flow
% of AUM
-0.51%
Top 10 Holdings %
Top 10 Hldgs %
30.01%
Holding
985
New
38
Increased
326
Reduced
528
Closed
39
Top Buys
| 1 |
Microsoft
MSFT
|
+$265M |
| 2 |
Apple
AAPL
|
+$234M |
| 3 |
Nu Holdings
NU
|
+$115M |
| 4 |
CRH
CRH
|
+$110M |
| 5 |
Broadridge
BR
|
+$82.5M |
Top Sells
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$132M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$88M |
| 3 |
ExxonMobil
XOM
|
+$67.8M |
| 4 |
Amazon
AMZN
|
+$56.6M |
| 5 |
Fomento Económico Mexicano
FMX
|
+$56.1M |
Sector Composition
| 1 | Technology | 31.84% |
| 2 | Healthcare | 16.47% |
| 3 | Financials | 10.07% |
| 4 | Consumer Discretionary | 9.02% |
| 5 | Industrials | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Blackstone Secured Lending
BXSL
$5.59B
| $1.6M | ﹤0.01% |
52,174
-5,323
| -9% | -$167K |
|
777
Fulcrum Therapeutics
FULC
$242M
| $1.59M | ﹤0.01% |
256,888
| – | – |
|
778
SEI Investments
SEIC
$11.9B
| $1.59M | ﹤0.01% |
24,552
-12,870
| -34% | -$865K |
|
|
XRN
779
Chiron Real Estate Inc
XRN
$547M
| $1.59M | ﹤0.01% |
34,979
| – | – |
|
780
HEICO Corp
HEI
$48.6B
| $1.58M | ﹤0.01% |
7,074
-8,379
| -54% | -$1.77M |
|
|
ABVX
781
Abivax
ABVX
$11.9B
| $1.56M | ﹤0.01% |
+118,206
| New | +$1.69M |
|
782
SPDR Gold Trust
GLD
$130B
| $1.55M | ﹤0.01% |
7,226
-3,103
| -30% | -$671K |
|
783
Paycom
PAYC
$6.82B
| $1.54M | ﹤0.01% |
10,772
-12,720
| -54% | -$2.18M |
|
784
EastGroup Properties
EGP
$12B
| $1.53M | ﹤0.01% |
8,989
+640
| +8% | +$106K |
|
785
Codexis
CDXS
$200M
| $1.53M | ﹤0.01% |
492,648
+332,067
| +207% | +$1.07M |
|
|
WCN
786
Waste Connections
WCN
$44.1B
| $1.52M | ﹤0.01% |
8,682
+1,435
| +20% | +$240K |
|
787
NewAmsterdam Pharma
NAMS
$3.68B
| $1.46M | ﹤0.01% |
+76,000
| New | +$1.52M |
|
|
RNAM
788
DELISTED
Avidity Biosciences
RNAM
| $1.46M | ﹤0.01% |
35,638
-93,776
| -72% | -$2.69M |
|
789
Remitly
RELY
$5.03B
| $1.45M | ﹤0.01% |
120,011
+4,758
| +4% | +$73.8K |
|
790
APA Corp
APA
$12.2B
| $1.45M | ﹤0.01% |
49,113
-81,147
| -62% | -$2.51M |
|
|
ALTM
791
DELISTED
Arcadium Lithium plc
ALTM
| $1.43M | ﹤0.01% |
+424,974
| New | +$1.78M |
|
792
Arcutis Biotherapeutics
ARQT
$3.53B
| $1.38M | ﹤0.01% |
148,874
| – | – |
|
793
Coursera
COUR
$1.57B
| $1.37M | ﹤0.01% |
191,396
+7,646
| +4% | +$72.7K |
|
794
Takeda Pharmaceutical
TAK
$54.9B
| $1.36M | ﹤0.01% |
105,073
| – | – |
|
795
Voya Financial
VOYA
$9.14B
| $1.35M | ﹤0.01% |
19,013
-13,541
| -42% | -$975K |
|
796
Robert Half
RHI
$4.2B
| $1.3M | ﹤0.01% |
20,287
-295,162
| -94% | -$20.2M |
|
797
EQT Corp
EQT
$31.2B
| $1.3M | ﹤0.01% |
35,079
+2,179
| +7% | +$85.4K |
|
|
MRNS
798
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.26M | ﹤0.01% |
1,080,198
+527,626
| +95% | +$1.32M |
|
799
Liberty Global Class C
LBTYK
$3.46B
| $1.23M | ﹤0.01% |
68,790
-3,969
| -5% | -$69.1K |
|
800
Ralph Lauren
RL
$22.7B
| $1.21M | ﹤0.01% |
6,929
-101
| -1% | -$17.4K |
|
Similar funds
Aberdeen Group's Q2 2024 Portfolio in Review
As of Q2 2024, Aberdeen Group held 985 positions worth $52.2B, up 2.3% from $51B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Aberdeen Group's Q2 2024 filing shows 38 new, 326 increased, 528 reduced and 39 closed positions. Its largest new stake was CRH: 1,378,142 shares worth $103M. The largest sale was Berkshire Hathaway Class B, an estimated $132M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
- Aberdeen Group's largest Q2 2024 buy was CRH: 1,378,142 shares worth $103M.
- Aberdeen Group added most to Microsoft in Q2 2024, an estimated $265M increase.
- Aberdeen Group's biggest Q2 2024 reduction was Berkshire Hathaway Class B, cutting an estimated $132M.
- Aberdeen Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $27.1M.
- Aberdeen Group's ten largest holdings make up 30% of its $52.2B portfolio in Q2 2024.
- Aberdeen Group opened 38 new positions and closed 39 in Q2 2024.
- Aberdeen Group's portfolio value rose 2.3% quarter-over-quarter to $52.2B.
Based on Aberdeen Group's 13F filing for Q2 2024, filed 9 Aug 2024.